6.
Pruim R, Welch R, Sanna S, Teslovich T, Chines P, Gliedt T
. LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics. 2010; 26(18):2336-7.
PMC: 2935401.
DOI: 10.1093/bioinformatics/btq419.
View
7.
Nanba K, Omata K, Gomez-Sanchez C, Stratakis C, Demidowich A, Suzuki M
. Genetic Characteristics of Aldosterone-Producing Adenomas in Blacks. Hypertension. 2019; 73(4):885-892.
PMC: 6416065.
DOI: 10.1161/HYPERTENSIONAHA.118.12070.
View
8.
Savard S, Amar L, Plouin P, Steichen O
. Cardiovascular complications associated with primary aldosteronism: a controlled cross-sectional study. Hypertension. 2013; 62(2):331-6.
DOI: 10.1161/HYPERTENSIONAHA.113.01060.
View
9.
Matsunaga Y, Noda M, Murakawa H, Hayashi K, Nagasaka A, Inoue S
. Reelin transiently promotes N-cadherin-dependent neuronal adhesion during mouse cortical development. Proc Natl Acad Sci U S A. 2017; 114(8):2048-2053.
PMC: 5338414.
DOI: 10.1073/pnas.1615215114.
View
10.
Dutta R, Welander J, Brauckhoff M, Walz M, Alesina P, Arnesen T
. Complementary somatic mutations of KCNJ5, ATP1A1, and ATP2B3 in sporadic aldosterone producing adrenal adenomas. Endocr Relat Cancer. 2013; 21(1):L1-4.
DOI: 10.1530/ERC-13-0466.
View
11.
Piluso G, DAmico F, Saccone V, Bismuto E, Rotundo I, Di Domenico M
. A missense mutation in CASK causes FG syndrome in an Italian family. Am J Hum Genet. 2009; 84(2):162-77.
PMC: 2668001.
DOI: 10.1016/j.ajhg.2008.12.018.
View
12.
Monticone S, Burrello J, Tizzani D, Bertello C, Viola A, Buffolo F
. Prevalence and Clinical Manifestations of Primary Aldosteronism Encountered in Primary Care Practice. J Am Coll Cardiol. 2017; 69(14):1811-1820.
DOI: 10.1016/j.jacc.2017.01.052.
View
13.
Scholl U, Stolting G, Schewe J, Thiel A, Tan H, Nelson-Williams C
. CLCN2 chloride channel mutations in familial hyperaldosteronism type II. Nat Genet. 2018; 50(3):349-354.
PMC: 5862758.
DOI: 10.1038/s41588-018-0048-5.
View
14.
Choi M, Scholl U, Yue P, Bjorklund P, Zhao B, Nelson-Williams C
. K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science. 2011; 331(6018):768-72.
PMC: 3371087.
DOI: 10.1126/science.1198785.
View
15.
Angelo K, Jespersen T, Grunnet M, Nielsen M, Klaerke D, Olesen S
. KCNE5 induces time- and voltage-dependent modulation of the KCNQ1 current. Biophys J. 2002; 83(4):1997-2006.
PMC: 1302289.
DOI: 10.1016/S0006-3495(02)73961-1.
View
16.
Shabalin A
. Matrix eQTL: ultra fast eQTL analysis via large matrix operations. Bioinformatics. 2012; 28(10):1353-8.
PMC: 3348564.
DOI: 10.1093/bioinformatics/bts163.
View
17.
Scholl U, Goh G, Stolting G, de Oliveira R, Choi M, Overton J
. Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism. Nat Genet. 2013; 45(9):1050-4.
PMC: 3876926.
DOI: 10.1038/ng.2695.
View
18.
Scholl U, Stolting G, Nelson-Williams C, Vichot A, Choi M, Loring E
. Recurrent gain of function mutation in calcium channel CACNA1H causes early-onset hypertension with primary aldosteronism. Elife. 2015; 4:e06315.
PMC: 4408447.
DOI: 10.7554/eLife.06315.
View
19.
Azizan E, Poulsen H, Tuluc P, Zhou J, Clausen M, Lieb A
. Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension. Nat Genet. 2013; 45(9):1055-60.
DOI: 10.1038/ng.2716.
View
20.
Lifton R, Dluhy R, Powers M, Rich G, Cook S, Ulick S
. A chimaeric 11 beta-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature. 1992; 355(6357):262-5.
DOI: 10.1038/355262a0.
View